Stock listing

Pegbio Co., Ltd. Class H

Selected listing: 2565 · HKEX · HKD · HK

Pegbio Co., Ltd. Class H (HKEX:2565), Health Technology. Latest release Jun 29, 2026: VOLUNTARY ANNOUNCEMENT CORE PRODUCT VISEPEGENATIDE INJECTION PASSED…

2565:HKEXHKDHKUpdated October 2, 2026
Pegbio Co., Ltd. Class H logo
Ticker
HKEX:2565
Asset type
Stock
Sector
Health Technology
Industry
Biotechnology
Exchange
HKEX
Currency
HKD

About Pegbio Co., Ltd. Class H

The company focuses on biotechnology and aims to advance healthcare solutions. Investors can find relevant information and updates about Pegbio's operations and performance on its public company page.

Latest news from Pegbio Co., Ltd. Class H

VOLUNTARY ANNOUNCEMENT CORE PRODUCT VISEPEGENATIDE INJECTION PASSED THE PRELIMINARY REVIEW IN ACCORDANCE WITH THE 2026 NATIONAL REIMBURSEMENT DRUG LIST ADJUSTMENT

June 29, 2026

Next Day Disclosure Return

June 26, 2026

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

June 24, 2026

All Pegbio Co., Ltd. Class H news →

Research Pegbio Co., Ltd. Class H

Pegbio Co., Ltd. Class H company profile

View the public company page for Pegbio Co., Ltd. Class H on 6ix.

Pegbio Co., Ltd. Class H news

Read company news and market updates connected to Pegbio Co., Ltd. Class H.

Pegbio Co., Ltd. Class H investor events

Find investor webinars, events, and replay context for Pegbio Co., Ltd. Class H.

Alternate listings

PGBIF:OTC

US · USD

Alternate listing for Pegbio Co., Ltd. Class H; the primary context on this page is 2565:HKEX.